1. The "gender factor" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study.
- Author
-
Colombo D, Abbruzzese G, Antonini A, Barone P, Bellia G, Franconi F, Simoni L, Attar M, Zagni E, Haggiag S, and Stocchi F
- Subjects
- Aged, Akathisia, Drug-Induced etiology, Antiparkinson Agents therapeutic use, Cross-Sectional Studies, Female, Gait drug effects, Humans, Levodopa therapeutic use, Male, Risk Factors, Severity of Illness Index, Sex Factors, Antiparkinson Agents adverse effects, Levodopa adverse effects, Parkinson Disease drug therapy
- Abstract
Background: The early detection of wearing-off in Parkinson disease (DEEP) observational study demonstrated that women with Parkinson's disease (PD) carry an increased risk (80.1%) for wearing-off (WO). This post hoc analysis of DEEP study evaluates gender differences on WO and associated phenomena., Methods: Patients on dopaminergic treatment for ≥ 1 year were included in this multicenter observational cross-sectional study. In a single visit, WO was diagnosed based on neurologist assessment as well as the use of the 19-item wearing-off questionnaire (WOQ-19); WO was defined for scores ≥ 2. Post hoc analyses were conducted to investigate gender difference for demographic and clinical features with respect to WO., Results: Of 617 patients enrolled, 236 were women and 381 were men. Prevalence of WO was higher among women, according to both neurologists' judgment (61.9% versus 53.8%, P = 0.045) and the WOQ-19 analysis (72.5% versus 64.0%, P = 0.034). In patients with WO (WOQ-19), women experienced ≥ 1 motor symptom in 72.5% versus 64.0% in men and ≥ 1 nonmotor symptom in 44.5% versus 36.7%, in men., Conclusions: Our results suggest WO as more common among women, for both motor and nonmotor symptoms. Prospective studies are warranted to investigate this potential gender-effect.
- Published
- 2015
- Full Text
- View/download PDF